2442 related articles for article (PubMed ID: 19041677)
1. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
2. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
[TBL] [Abstract][Full Text] [Related]
3. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague.
Veits J; Lüschow D; Kindermann K; Werner O; Teifke JP; Mettenleiter TC; Fuchs W
J Gen Virol; 2003 Dec; 84(Pt 12):3343-3352. PubMed ID: 14645915
[TBL] [Abstract][Full Text] [Related]
6. Development and use of fowlpox vectored vaccines for avian influenza.
Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
[TBL] [Abstract][Full Text] [Related]
7. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
Qiao CL; Yu KZ; Jiang YP; Jia YQ; Tian GB; Liu M; Deng GH; Wang XR; Meng QW; Tang XY
Avian Pathol; 2003 Feb; 32(1):25-32. PubMed ID: 12745375
[TBL] [Abstract][Full Text] [Related]
8. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
10. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
11. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
12. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.
Li C; Ping J; Jing B; Deng G; Jiang Y; Li Y; Tian G; Yu K; Bu Z; Chen H
Biochem Biophys Res Commun; 2008 Jul; 372(2):293-7. PubMed ID: 18501701
[TBL] [Abstract][Full Text] [Related]
13. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
Jiang Y; Yu K; Zhang H; Zhang P; Li C; Tian G; Li Y; Wang X; Ge J; Bu Z; Chen H
Antiviral Res; 2007 Sep; 75(3):234-41. PubMed ID: 17451817
[TBL] [Abstract][Full Text] [Related]
14. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens.
Ramp K; Veits J; Deckers D; Rudolf M; Grund C; Mettenleiter TC; Römer-Oberdörfer A
Avian Dis; 2011 Sep; 55(3):413-21. PubMed ID: 22017039
[TBL] [Abstract][Full Text] [Related]
16. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene.
Lüschow D; Werner O; Mettenleiter TC; Fuchs W
Vaccine; 2001 Jul; 19(30):4249-59. PubMed ID: 11457552
[TBL] [Abstract][Full Text] [Related]
17. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Rauw F; Palya V; Van Borm S; Welby S; Tatar-Kis T; Gardin Y; Dorsey KM; Aly MM; Hassan MK; Soliman MA; Lambrecht B; van den Berg T
Vaccine; 2011 Mar; 29(14):2590-600. PubMed ID: 21292007
[TBL] [Abstract][Full Text] [Related]
18. New DIVA vaccine for the protection of poultry against H5 highly pathogenic avian influenza viruses irrespective of the N-subtype.
Peeters B; de Boer SM; Tjeerdsma G; Moormann R; Koch G
Vaccine; 2012 Nov; 30(49):7078-83. PubMed ID: 23036502
[TBL] [Abstract][Full Text] [Related]
19. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
20. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
